Risk Ratio for Coronary Heart Disease Mortality in 59 Randomized Controlled Trials of Cholesterol-Lo...
This presentation is the property of its rightful owner.
Sponsored Links
1 / 3

Statins0.69 (0.59-0.80) n=13 (16,228/11,279) n-3 fatty acids0.44 (0.18-1.07) PowerPoint PPT Presentation


  • 69 Views
  • Uploaded on
  • Presentation posted in: General

Risk Ratio for Coronary Heart Disease Mortality in 59 Randomized Controlled Trials of Cholesterol-Lowering Interventions. Risk Ratio % 95% CI. Benefit. Harm. Statins0.69 (0.59-0.80) n=13 (16,228/11,279) n-3 fatty acids0.44 (0.18-1.07) n=3 (1,348/1,349) Fibrates0.98 (0.78-1.24)

Download Presentation

Statins0.69 (0.59-0.80) n=13 (16,228/11,279) n-3 fatty acids0.44 (0.18-1.07)

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -

Presentation Transcript


Statins 0 69 0 59 0 80 n 13 16 228 11 279 n 3 fatty acids 0 44 0 18 1 07

Risk Ratio for Coronary Heart Disease Mortality in 59 Randomized Controlled Trials of Cholesterol-Lowering Interventions

Risk Ratio % 95% CI

Benefit

Harm

Statins0.69 (0.59-0.80)

n=13 (16,228/11,279)

n-3 fatty acids0.44 (0.18-1.07)

n=3 (1,348/1,349)

Fibrates0.98 (0.78-1.24)

n=12 (9,873/11,496)

Resins0.71 (0.51-0.99)

n=8 (3,280/3,257

Hormones1.04 (0.93-1.17)

n=8 (4,516/9,039)

Niacin acids0.85 (0.83-1.10)

n=2 (1,196/2,932)

Diet0.91 (0.82-1.01)

n=16 (48,481/59,042)

.1

.2

.3

.4

.5

.6

.7

.8

.9

1.0

2

Arterioscler Thromb Vasc Biol. 1999;19:187-195


Statins 0 69 0 59 0 80 n 13 16 228 11 279 n 3 fatty acids 0 44 0 18 1 07

Risk Ratio for Overall Mortality in 59 Randomized Controlled Trials of Cholesterol-Lowering Interventions

Risk Ratio % 95% CI

Benefit

Harm

Statins0.79 (0.71-0.89)

n=13 (16,228/11,279)

n-3 fatty acids0.66 (0.53-0.88)

n=3 (1,348/1,349)

Fibrates1.06 (0.78-1.48)

n=12 (9,873/11,496)

Resins0.85 (0.66-1.08)

n=8 (3,280/3,257

Hormones1.09 (1.00-1.20)

n=8 (4,516/9,039)

Niacin acids0.96 (0.86-1.08)

n=2 (1,196/2,932)

Diet0.97 (0.81-1.15)

n=16 (48,441/59,042)

.4

.5

.6

.7

.8

.9

1.0

2

Arterioscler Thromb Vasc Biol. 1999;19:187-195


Statins 0 69 0 59 0 80 n 13 16 228 11 279 n 3 fatty acids 0 44 0 18 1 07

Risk Ratio for Mortality Other Than From CHD in 59 Randomized Controlled Trials of Cholesterol-Lowering Interventions

Risk Ratio % 95% CI

Benefit

Harm

Statins0.97 (0.81-1.16)

n=13 (16,228/11,279)

n-3 fatty acids1.16 (0.63-2.12)

n=3 (1,348/1,349)

Fibrates1.16 (0.63-2.12)

n=12 (9,873/11,496)

Resins1.07 (0.74-1.55)

n=8 (3,280/3,257

Hormones1.29 (1.08-1.57)

n=8 (4,516/9,039)

Niacin acids0.99 (0.76-1.29)

n=2 (1,196/2,932)

Diet1.00 (0.95-1.05)

n=16 (48,481/59,042)

.6

.7

.8

.9

1.0

2

3

Arterioscler Thromb Vasc Biol. 1999;19:187-195


  • Login